CRISPR CLINICAL TRIALS

Antibacterial

Indicator
IND Enabling
Phase I
Phase II
Phase III

Blood

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
HIV-1-infection
Sponsors:

Affiliated Hospital to Academy of Military Medical Sciences

IND Enabling
Phase I
Phase II
Phase III

Cancer

Indicator
IND Enabling
Phase I
Phase II
Phase III
Nasopharyngeal Carcinoma
Sponsors:

Yang Yang, MD, PhD, MSCR, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumor, Adult
Sponsors:

Chinese PLA General Hospital

Indicator
IND Enabling
Phase I
Phase II
Phase III
Multiple Solid Tumor, Adult
Sponsors:

Chinese PLA General Hospital

Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
B Cell Lymphoma
Sponsors:

Chinese PLA General Hospital

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III

Eye

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III